Question 1

What is Jin Li?

Accepted Answer

Jin Li is a Person.

Question 2

How often does Jin Li appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 40 articles.

Question 3

When was Jin Li first tracked by Ergen?

Accepted Answer

First tracked on Apr 29, 2026.

Question 4

When was Jin Li last mentioned in news?

Accepted Answer

Last active on Jul 14, 2026.

Question 5

What is Jin Li's current news sentiment?

Accepted Answer

Aggregate sentiment score: 25 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Jin Li in global news coverage?

Accepted Answer

Attention score of 7, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Jin Li?

Accepted Answer

ASCO 2026 Oncology Research Presentations (May 25, 2026, 33 articles).

Question 8

How did the "ASCO 2026 Oncology Research Presentations" event impact Jin Li?

Accepted Answer

Professor Jin Li co-led the HORIZON-CRC01 study, which demonstrated improved progression-free survival with trastuzumab rezetecan in advanced colorectal cancer.

Question 9

How did the "BGE-102 Phase 2 trial dosed" event impact Jin Li?

Accepted Answer

As CEO of HitGen, Jin Li commented positively on the milestone, reflecting leadership in the collaboration.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.